Randee’s cancer had metastasized. When her doctor tested her for the PIK3CA gene mutation, she was able to make informed ...

Artificial intelligence is gaining ground in healthcare, and tech's biggest players are racing to stake their claims.

First-line treatment with nivolumab (Opdivo) and ipilimumab (Yervoy) significantly improved survival compared with lenvatinib ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), the Breast International Group (BIG), Institut Jules Bordet Clinical Trials Support Unit and Frontier Science Foundation, announced ...

Open Molecules 2025, an unprecedented dataset of molecular simulations, has been released to the scientific community, paving ...

As the FDA prepares for a busy Oncologic Drugs Advisory Committee next week, an agency insider told BioSpace that volunteers ...

Rising prevalence, aging populations, and therapeutic innovation are reshaping the landscape of multiple myeloma care and driving sustained market gr ...

Genentech, American-headquartered in San Francisco, plans 420 jobs for the Wake County community of Holly Springs just outside of Raleigh.

Focused Research Symposium Highlighting Recent Innovations in the Field SOUTH SAN FRANCISCO, Calif., May 15, 2025 (GLOBE ...

Mucus plugs affect some 40% to nearly 70% of COPD patients, and even clinically silent mucus plugs are linked to poorer ...

Kazia Therapeutics Limited ("Kazia" or the "Company"), an oncology-focused drug development company, today announced a summary of its recent progress across its business and also provided a business ...

President Donald Trump's plans to dramatically slash drug prices for Americans could make Swiss pharmaceutical giant Roche cancel major investments in ...